Palatine, Ill., April 21, 2010 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) today reported a first quarter 2010 net loss of $4.0 million or $0.09 per share compared to net loss of $1.3 million or $0.03 per share for the first quarter 2009. As of April 20, 2010, we had cash and cash equivalents of approximately $26.9 million with no term indebtedness.
